Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![asxpeasant Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1071574424371875842.png) Peasant [@asxpeasant](/creator/twitter/asxpeasant) on x 5029 followers
Created: 2025-07-17 00:15:30 UTC

$CU6 clarity Pharma is going HEAD TO HEAD with $TLX leading breadwinner Ga-PSMA-11. 

(TLX $10B cap)

Nobody has come out of the woods to tell me why cu6 isn’t going to take the whole cake off $TLX when it comes to the safety and efficacy of this trial.

Does anyone disagree?

![](https://pbs.twimg.com/media/GwBL29sW4AEHKxH.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945638455041823043/c:line.svg)

**Related Topics**
[$10b](/topic/$10b)
[$tlx](/topic/$tlx)
[clarity](/topic/clarity)
[$cu6](/topic/$cu6)

[Post Link](https://x.com/asxpeasant/status/1945638455041823043)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

asxpeasant Avatar Peasant @asxpeasant on x 5029 followers Created: 2025-07-17 00:15:30 UTC

$CU6 clarity Pharma is going HEAD TO HEAD with $TLX leading breadwinner Ga-PSMA-11.

(TLX $10B cap)

Nobody has come out of the woods to tell me why cu6 isn’t going to take the whole cake off $TLX when it comes to the safety and efficacy of this trial.

Does anyone disagree?

XXXXX engagements

Engagements Line Chart

Related Topics $10b $tlx clarity $cu6

Post Link

post/tweet::1945638455041823043
/post/tweet::1945638455041823043